SE402915B - Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan - Google Patents
Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkanInfo
- Publication number
- SE402915B SE402915B SE7214358A SE1435872A SE402915B SE 402915 B SE402915 B SE 402915B SE 7214358 A SE7214358 A SE 7214358A SE 1435872 A SE1435872 A SE 1435872A SE 402915 B SE402915 B SE 402915B
- Authority
- SE
- Sweden
- Prior art keywords
- triazinones
- imidazo
- procedure
- preparation
- therapeutic effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5375071A GB1400999A (en) | 1971-11-19 | 1971-11-19 | Imidazo-triazine compounds and their use in therapeutic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE402915B true SE402915B (sv) | 1978-07-24 |
Family
ID=10468856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7214358A SE402915B (sv) | 1971-11-19 | 1972-11-06 | Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3840537A (sv) |
| JP (1) | JPS563873B2 (sv) |
| AT (1) | AT321923B (sv) |
| AU (1) | AU472127B2 (sv) |
| BE (1) | BE791025A (sv) |
| CA (1) | CA990292A (sv) |
| CH (1) | CH594671A5 (sv) |
| DE (1) | DE2255172A1 (sv) |
| DK (1) | DK138691B (sv) |
| ES (1) | ES408736A1 (sv) |
| FR (1) | FR2160407B1 (sv) |
| GB (1) | GB1400999A (sv) |
| IE (1) | IE37046B1 (sv) |
| IL (1) | IL40686A (sv) |
| NL (1) | NL7215646A (sv) |
| PH (1) | PH9669A (sv) |
| SE (1) | SE402915B (sv) |
| ZA (1) | ZA727532B (sv) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1457873A (en) * | 1973-01-04 | 1976-12-08 | Allen & Hanburys Ltd | Imidazotriazines |
| DE2314488C3 (de) * | 1973-03-23 | 1979-01-04 | C.H. Boehringer Sohn, 6507 Ingelheim | 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel |
| DE2335193A1 (de) * | 1973-07-11 | 1975-01-30 | Hoechst Ag | Bis-triazinobenzimidazole und ihre herstellung |
| USRE30511E (en) * | 1977-02-03 | 1981-02-10 | American Cyanamid Company | Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones |
| US4107307A (en) * | 1977-02-03 | 1978-08-15 | American Cyanamid Company | Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones |
| US4115572A (en) * | 1977-02-03 | 1978-09-19 | American Cyanamid Company | Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma |
| DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
| US4107308A (en) * | 1977-10-18 | 1978-08-15 | American Cyanamid Company | Imidazo[1,5-d]-as-triazines |
| US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
| HU187474B (en) * | 1981-11-18 | 1986-01-28 | Gyogyszerkutato Intezet,Hu | Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives |
| US4395547A (en) * | 1982-02-10 | 1983-07-26 | American Cyanamid Co. | Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones |
| AU622330B2 (en) * | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| CH693954A5 (de) | 1997-11-12 | 2004-05-14 | Bayer Ag | 2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase Inhibitoren. |
| DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
| CN1314811A (zh) | 1998-08-26 | 2001-09-26 | 史密丝克莱恩比彻姆公司 | 治疗肺病的方法 |
| CN1202865C (zh) | 1999-08-21 | 2005-05-25 | 奥坦纳医药公司 | 增效组合物 |
| EP1392314B1 (de) * | 2001-05-09 | 2006-12-20 | Bayer HealthCare AG | NEUE VERWENDUNG VON 2-[2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| US7462614B2 (en) * | 2003-04-01 | 2008-12-09 | Smithkline Beecham Corporation | Imidazotriazine compounds |
| ES2328833T3 (es) | 2004-04-02 | 2009-11-18 | Osi Pharmaceuticals, Inc. | Inhibidores de proteina quinasa heterobiciclicos con anillo 6,6-biciclico. |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| WO2007039075A2 (en) * | 2005-09-29 | 2007-04-12 | Bayer Healthcare Ag | Pde inhibitors and combinations thereof for the treatment of urological disorders |
| DK1951724T3 (da) * | 2005-11-17 | 2011-08-15 | Osi Pharmaceuticals Llc | Sammensmeltede bicykliske mTOR-inhibitorer |
| US20100184769A1 (en) * | 2007-06-13 | 2010-07-22 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| WO2010123792A1 (en) | 2009-04-20 | 2010-10-28 | Osi Pharmaceuticals, Inc. | Preparation of c-pyrazine-methylamines |
| CN103374002B (zh) * | 2012-04-19 | 2015-07-15 | 山东轩竹医药科技有限公司 | 磷酸二酯酶-5抑制剂 |
| WO2016147659A1 (en) * | 2015-03-16 | 2016-09-22 | Sumitomo Dainippon Pharma Co., Ltd. | Bicyclic imidazolo derivative |
| WO2017000276A1 (en) * | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
| WO2017204316A1 (ja) * | 2016-05-27 | 2017-11-30 | 塩野義製薬株式会社 | ５－オキソ－１，２，４－トリアジン誘導体およびその医薬組成物 |
-
0
- BE BE791025D patent/BE791025A/xx unknown
-
1971
- 1971-11-19 GB GB5375071A patent/GB1400999A/en not_active Expired
-
1972
- 1972-10-23 DK DK525172AA patent/DK138691B/da unknown
- 1972-10-23 ZA ZA727532A patent/ZA727532B/xx unknown
- 1972-10-23 IE IE1433/72A patent/IE37046B1/xx unknown
- 1972-10-25 US US00300749A patent/US3840537A/en not_active Expired - Lifetime
- 1972-10-26 AU AU48191/72A patent/AU472127B2/en not_active Expired
- 1972-10-27 IL IL40686A patent/IL40686A/xx unknown
- 1972-11-01 CA CA155,720A patent/CA990292A/en not_active Expired
- 1972-11-06 SE SE7214358A patent/SE402915B/sv unknown
- 1972-11-08 FR FR7239498A patent/FR2160407B1/fr not_active Expired
- 1972-11-10 DE DE2255172A patent/DE2255172A1/de not_active Withdrawn
- 1972-11-16 CH CH1668372A patent/CH594671A5/xx not_active IP Right Cessation
- 1972-11-16 PH PH14090*UA patent/PH9669A/en unknown
- 1972-11-17 ES ES408736A patent/ES408736A1/es not_active Expired
- 1972-11-17 JP JP11549572A patent/JPS563873B2/ja not_active Expired
- 1972-11-17 AT AT982372A patent/AT321923B/de not_active IP Right Cessation
- 1972-11-17 NL NL7215646A patent/NL7215646A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA990292A (en) | 1976-06-01 |
| PH9669A (en) | 1976-02-10 |
| US3840537A (en) | 1974-10-08 |
| JPS4857993A (sv) | 1973-08-14 |
| GB1400999A (en) | 1975-07-16 |
| CH594671A5 (sv) | 1978-01-13 |
| FR2160407B1 (sv) | 1975-10-17 |
| ES408736A1 (es) | 1976-03-01 |
| JPS563873B2 (sv) | 1981-01-27 |
| DK138691B (da) | 1978-10-16 |
| DE2255172A1 (de) | 1973-05-24 |
| ZA727532B (en) | 1973-07-25 |
| AU4819172A (en) | 1974-05-16 |
| FR2160407A1 (sv) | 1973-06-29 |
| IE37046B1 (en) | 1977-04-27 |
| NL7215646A (sv) | 1973-05-22 |
| BE791025A (fr) | 1973-05-07 |
| IL40686A (en) | 1975-12-31 |
| AT321923B (de) | 1975-04-25 |
| AU472127B2 (en) | 1976-05-20 |
| IE37046L (en) | 1973-05-19 |
| DK138691C (sv) | 1979-03-26 |
| IL40686A0 (en) | 1972-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE402915B (sv) | Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan | |
| SE405604B (sv) | Analogiforfarande for framstellning av 1,2,4-triazol-3-karboxamid-1-(beta-d-ribofuranosyl) | |
| SE384211B (sv) | Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
| SE392269B (sv) | Forfarande for framstellning av vissa indanyloxitetrazoler | |
| SE395890B (sv) | Forfarande for framstellning av anthelmintiskt verksamma 2-karbalkoxiamino-bensimidazol-5 (6)-fenyletrar | |
| NO137012C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrazolo (1,5-a)-pyrimidiner | |
| SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
| FI54121C (fi) | Foerfarande foer framstaellning av blodtryckssaenkande imidazo-(1,2-a)-imidazoler -pyrimidiner och diazepiner och deras syraadditionssalter | |
| SE396388B (sv) | Analogiforfrande for framstellning av 2,3-dihydro-oxo-imidazo-/1,2-a/pyrimidiner | |
| SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
| SE398499B (sv) | Forfarande for framstellning av 2,4,5,6-tetrahydrocyklopenta/c/purrol-4-karboxamider och -4-tiokarboxamider med terapeutisk verkan | |
| SE386175B (sv) | Forfarande for framstellning av 1,4-bis-acylpiperaziner | |
| SE380804B (sv) | Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4) | |
| SE7507887L (sv) | Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan. | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| SE398122B (sv) | Analogiforfarande for framstellning av pyrazino/1,2-a/indol-2-karboxamidiner | |
| SE390025B (sv) | Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion | |
| SE409866B (sv) | Forfarande for framstellning av adenosinderivat | |
| SE393980B (sv) | Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan | |
| SE395689B (sv) | Forfarande for framstellning av vissa angivna bensalacetonamidinohydrazonderivat med antiviral verkan | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler | |
| SE394430B (sv) | Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan | |
| SE385897B (sv) | Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan | |
| SE400777B (sv) | Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner med antibakteriell verkan |